{
    "Project Title": "InterStim Amplitude Study",
    "Sponsor": "Medtronic, Inc.",
    "Study Number": "MDT17030",
    "Protocol Version and Date": "Version 2.0",
    "Study Title": "InterStim Amplitude Study",
    "Phase": "Not Available",
    "Therapeutic Area": "Overactive Bladder (OAB)",
    "Number of Patients": "Approximately 60 subjects are estimated to be enrolled",
    "Number of Sites": "Approximately 20 clinical sites",
    "Indication": "Overactive bladder (OAB)",
    "Duration of Treatment": "Approximately 16 weeks",
    "Schedule of Assessments": "Refer to Figure 9-1",
    "questionnaires": [
        {
            "longName": "International Consultation on Incontinence Modular Questionnaire - Overactive Bladder Symptoms Quality of Life Questionnaire (ICIQ-OABqol)",
            "shortName": "ICIQ-OABqol",
            "type": "PRO",
            "questionnaireSchedule": "Enrollment/Baseline; 12-Week Follow-up Visit",
            "questionnaireTiming": [
                "Enrollment /  Baseline",
                "12-Week Follow-Up Visit (+/- 7 days)"
            ]
        },
        {
            "longName": "3-Day Voiding Diary",
            "shortName": "Voiding Diary",
            "type": "PRO",
            "questionnaireSchedule": "Completed prior to each follow-up visit, and at the end of therapy evaluation period",
            "questionnaireTiming": [
                "Enrollment /  Baseline",
                "Therapy Evaluation",
                "6-Week Follow-Up Visit (+/- 7 days)",
                "12-Week Follow-Up Visit (+/- 7 days)",
                "Unscheduled Visit"
            ]
        },
        {
            "longName": "Patient Global Impression of Improvement (PGI-I)",
            "shortName": "PGI-I",
            "type": "ClinRO",
            "questionnaireSchedule": "1-Week Follow-up Visit; 6-Week Follow-up Visit",
            "questionnaireTiming": [
                "6-Week Follow-Up Visit (+/- 7 days)",
                "12-Week Follow-Up Visit (+/- 7 days)"
            ]
        }
    ]
}